| Name | Title | Contact Details |
|---|
ALB is a leading and innovative cloud and web-based platform built by industry experts and lawyers for assisting law firms across the world. ALB is an all-inclusive platform with an easy-to-use dashboard that helps the law firms timekeepers to easily capture details of their daily activities using our mobile or web app. ALB also helps the law firms billing clerk or department to easily prepare and submit accurate invoices to their clients. What makes ALB stand out from any other legal billing software is ALBs skill in being intuitive and to make corrections on line items based on a firms client SLA such that the law firms suffer zero to minimal losses on their invoice amount. Owing to ALBs latest technology, law firms can now prepare and submit invoices to clients that are 100% compliant with their clients SLA. This then results in the firms invoices being processed much faster by a legal bill review vendor or the clients in-house team. Hence the payments are processed much quicker ensuring better cashflow for the firms. Long gone are the days when legal bill vendors cause reductions to the law firms bills.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Started with nothing more than a vision and an entrepreneurial spirit, AmeriLux International was formed in May 2004. AmeriLux is a value-adding distributor of multiwall and corrugated polycarbonate sheet products, PVC sheet and liner panels, and steel coil. Headquartered in De Pere, Wisconsin, AmeriLux sources and distributes materials from and to companies around the world. It is by building and maintaining strategic, win-win partnerships with vendors, customers, and employees that AmeriLux is able to profitably – and sustainably – grow its business. With an emphasis on customer service and support, AmeriLux International seeks to provide its customers with creative, cost-effective solutions to their unique challenges. This solutions-focused mentality has driven facility expansions and key equipment investments, enabling AmeriLux to provide a variety of fabrication services, component assembly, and turn-key manufacturing solutions. Strongly committed to educating the architectural, building, and construction communities on the benefits of using its products, AmeriLux International provides distance learning courses, webinars, and in-person presentations whereby continuing education units can be earned. These online educational programs are free, one-hour-long programs that focus on topics such as energy efficiency, polycarbonate glazing solutions, and sustainable design. This has led to a greater grass roots demand for their products. To reduce lead times and improve on-time delivery with key customers, AmeriLux International started AmeriLux Transportation — a trucking company with its own drivers and equipment — in June 2012. AmeriLux Transportation is a direct delivery carrier and regularly operates in the US. With the recent formation of AmeriLux Logistics, AmeriLux now has access to a network of qualified carriers and a wide range of freight shipping services - yet another offering to better serve the marketplace!
The New York Jets are a professional football team headquartered in Florham Park, New Jersey, representing the New York metropolitan area. It is a privately owned business with under 200 employees. Founded more than 50 years ago, the Jets franchise has defined itself as a trailblazer, trendsetter and leader in the regions sports landscape and across the NFL. Since Chairman and CEO Woody Johnson purchased the team in 2000, the team has undergone a major revitalization and rebranding, focused on winning both on and off the field. For Johnson, capturing the franchises second championship is priority #1. Under his ownership, the team has posted seven winning seasons, appeared in seven postseason games, including two AFC Championship Game appearances, and winning an AFC East division title in 2002. They have also made strides off the field with the opening of two state-of-the-art homes: the Atlantic Health Jets Training Center in 2008 and MetLife Stadium in 2010. Honored as one of NJ Bizs 2018 Best Places to Work in New Jersey. This award recognizes and honors New Jersey-based employers who show dedication to their employees professional growth and quality of life.